Takeda Pharmaceutical
TAK
#430
Rank
NZ$83.17 B
Marketcap
$26.35
Share price
-0.36%
Change (1 day)
11.69%
Change (1 year)

Earnings for Takeda Pharmaceutical (TAK)

Earnings in 2024 (TTM): NZ$3.61 Billion

According to Takeda Pharmaceutical's latest financial reports the company's current earnings are NZ$29.97 Billion. a decrease over its 2023 earnings that were of NZ$3.98 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Takeda Pharmaceutical from 2009 to 2024

Annual earnings

Year Earnings Change
2024 NZ$3.90 B-1.9%
2023 NZ$3.98 B-28.11%
2022 NZ$5.53 B-41.15%
2021 NZ$9.41 B78.15%
2020 NZ$5.28 B246.83%
2019 NZ$1.52 B-48.74%
2018 NZ$2.97 B-23.86%
2017 NZ$3.90 B21.77%
2016 NZ$3.20 B-253.22%
2015 -NZ$2.1 Billion-159.7%
2014 NZ$3.50 B12.76%
2013 NZ$3.10 B2.7%
2012 NZ$3.02 B-57.11%
2011 NZ$7.05 B-10.11%
2010 NZ$7.84 B-4.2%
2009 NZ$8.19 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$30.41 B 678.64%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$13.84 B 254.55%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$12.10 B 209.95%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$23.78 B 508.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-NZ$1.38 Billion-135.29%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.53 B-60.71%๐Ÿ‡ฎ๐Ÿ‡ณ India
NZ$8.03 B 105.75%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.27 B 86.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$26.10 B 568.42%๐Ÿ‡บ๐Ÿ‡ธ USA